Enterprise Pharmacy Forward

2025

Opioid Wizard: Advancing identification and engagement in opioid use disorder care

Opioid Wizard: Advancing identification and engagement in opioid use disorder care

Author: Eric Wright As part of a national initiative to improve care for patients with opioid use disorder (OUD), Geisinger Enterprise Pharmacy contributed to the development and evaluation of Opioid Wizard — a clinical decision support tool embedded in the electronic health record. Designed to assist clinicians in identifying patients with

One year of CAR-T therapy: Advancing personalized cancer treatment at Geisinger

Authors: Lori Stopper, RPh, PharmD, Kayla Aufiero, RPh, PharmD Geisinger Medical Center in Danville and the Geisinger Cancer Institute have successfully completed the first year of chimeric antigen receptor T-cell (CAR-T) therapy infusions, treating 12 patients with the goal of achieving long-term remission — or even a potential

Geisinger Cancer Center Dickson City opens, expanding access to advanced oncology care

Authors: Justine Zuk and Ralph Ferraro On June 23, the new Geisinger Cancer Center Dickson City welcomed its first patient, marking a major milestone in the expansion of advanced cancer care across northeastern Pennsylvania. This momentous occasion reflects the culmination of months of tireless dedication and teamwork. Every member of

Tenecteplase is here: Navigating the shift of a stroke thrombolytic in the United States prior to FDA approval: a mini-review on rationale, barriers and pathways

Authors: Julian M. Burwell, Jason R. Howay, Lisa Wasko, Samantha Doucoure, Jamie L. Kerestes, Clemens M. Schirmer, David Ermak, Anthony Noto, Philipp Hendrix Until March 2025, alteplase (TPA) was the sole thrombolytic agent approved by the U.S. Food and Drug Administration (FDA) for the treatment of acute ischemic stroke

Geisinger Pharmacy services: Our integrated pharmacy network

Author: Stephanie Gill Geisinger’s integrated pharmacy network continues to support high-quality, cost-effective, evidence-based medication therapy management across central, south-central and northeastern Pennsylvania. Serving more than 1 million residents in 45 counties, the network includes 50+ pharmacy locations encompassing inpatient, outpatient, ambulatory care, home infusion and

Smart automation in cleanrooms: Metasys enhances sterile compounding compliance at Geisinger

Authors: Nichole Varela-Gonzalez and Adam Castro In hospital cleanrooms, where sterile compounding and infusion medication preparation occur, maintaining strict environmental controls is essential to patient safety and regulatory compliance. As standards governing compounding spaces have become increasingly rigorous — particularly with the implementation of USP <797> and USP

Strategic system transition: GHIS adopts Epic to advance home infusion services

Authors: Ron Zsido, Anthony Dicriscio and Jessica Koch The year 2024 marked a transformative milestone for Geisinger Home Infusion Services (GHIS), as the organization initiated a strategic transition from its long-standing CPR+ operating system to Epic. This shift is expected to redefine workflows, elevate patient care and align GHIS